CVS Health 3Q 2026: Revenue $108.4B, EPS $1.68— 10-Q Summary
CVS Health reported Q3 2026 revenue of $108.4B, up 5.4% YoY, and net income of $2.17B, reversing a prior-year loss. EPS was $1.68. Health Services revenue rose 9.5%, while Pharmacy & Consumer Wellness declined 2.0%. The company plans to split into two entities by mid-2028.
How this was made
The 30-second read
Why it matters
The earnings beat and profit swing are likely to trigger a short‑term price rally, especially in after‑hours trading.
Market read
First‑report earnings of a mega‑cap health‑care company, providing fresh data for traders.
What to watch
Potential headwinds from drug price reductions and reimbursement pressure on pharmacy segment.
Background
CVS Health filed its Q3 2026 10‑Q, showing a turnaround from a prior‑year loss to profit.
Ticker impact
CVS Health reported Q3 2026 revenue of $108.4B and a swing to $2.17B net income with EPS $1.68, a material earnings surprise.
upward pressure as investors price in profit swing and revenue growth
Revenue up 5.4% YoY and a turnaround from loss to profit are strong fundamentals that typically lift the stock.
Market effects
Healthcare services and retail pharmacy segments may see broader sentiment lift.
U.S. healthcare sector gains modest support.
Large-cap earnings can influence global health‑care indices.
Counterpoint
If guidance is weak or margins compress, the rally could be short‑lived.
Key entities
- companyCVS Health
U.S. health‑care and retail pharmacy operator.
